ABT-494

Another death mars AbbVie’s latest batch of promising data for its star rheumatoid arthritis drug
BioPharma Dive
Wed, 12/20/17 - 11:42 am
AbbVie
rheumatoid arthritis
Upadacitinib
ABT-494
AbbVie keen on JAK inhibitor despite safety concerns
BioPharma Dive
Tue, 09/12/17 - 04:22 pm
AbbVie
JAK inhibitors
Upadacitinib
ABT-494
rheumatoid arthritis
AbbVie reports two patient deaths in rheumatoid arthritis study
Yahoo/Reuters
Mon, 09/11/17 - 09:25 am
AbbVie
clinical trials
rheumatoid arthritis
Upadacitinib
ABT-494
AbbVie adds more stellar data on ABT-494 — this time for atopic dermatitis
Endpoints
Thu, 09/7/17 - 09:46 am
AbbVie
ABT-494
atopic dermatitis
Upadacitinib
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Mon, 11/28/16 - 11:33 pm
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
How AbbVie Plans To Replace Humira
Seeking Alpha
Tue, 04/12/16 - 07:43 am
AbbVie
Humira
R&D
autoimmune disease
ABT-122
ABT-494
ABBV-247
ALX-0061
AbbVie Announces the Launch of Robust Phase 3 Clinical Trial Program Evaluating ABT-494, an Investigational Selective JAK1 Inhibitor, for the Treatment of Rheumatoid Arthritis
Yahoo
Fri, 01/8/16 - 09:49 am
AbbVie
rheumatoid arthritis
JAK inhibitors
ABT-494
AbbVie dumps Galapagos' arthritis drug and presses on with its own
Fierce Biotech
Fri, 09/25/15 - 10:13 am
AbbVie
Galapagos
rheumatoid arthritis
ABT-494
JAK inhibitors
AbbVie Has Some Excellent Entries In Rheumatoid Arthritis
Seeking Alpha
Fri, 01/2/15 - 07:35 pm
AbbVie
rheumatoid arthritis
ABT-494
ABT-122
ALX-0061
Tregalizumab